Variant · Snv
TAP2 NM_001290043.2(TAP2):c.-4-15C>G
CI-VAR-00395509Explore in graph →NM_001290043.2:c.-4-15C>GClinVar 4326461
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 4326461 | Benign | criteria provided, single submitter | 1 | Chronic lymphocytic leukemia/small lymphocytic lymphoma; Cervical cancer; Uterine corpus endometrial carcinoma; Sarcoma; Lung cancer; Ovarian cancer; Ovarian serous cystadenocarcinoma; Thyroid cancer, nonmedullary, 1; Melanoma; Nonpapillary renal cell carcinoma | germline | 2 | Apr 08, 2026 | clinvar |